A large-scale international study published in the New England Journal of Medicine has confirmed that supervised physical exercise not only lowers the risk of cancer recurrence but also enhances overall survival in colon cancer patients. This is the first strong evidence supporting physical activity as an effective complementary treatment following chemotherapy.
Strong results after 8 years of follow-up
The clinical trial, carried out between 2009 and 2024, included 889 participants diagnosed with high-risk stage II or III colon cancer. All had undergone surgery and completed chemotherapy between 2-6 months prior to inclusion. Patients were randomly assigned to two groups: one group (445 people) followed a supervised physical exercise programme, while the other (444 people) received only general information on healthy lifestyles, with no specific programme or follow-up.
With an average follow-up period of 7.9 years, the results showed a clear difference between the groups:
Five-year disease-free survival was 80.3% in the exercise group, compared with 73.9% in the control group. This represents a 28% reduction in the risk of relapse or death.
Eight-year overall survival was also higher in the physically active group: 90.3%, compared with 83.2% in the group that received only health education.